Jennie Young was one of the first patients to receive Veyonda, Noxopharm’s (ASX: NOX) proprietary drug. Administered on compassionate grounds, her doctors believe that she responded to it positively. She had leiomyosarcoma, a rare cancer that affects smooth muscle tissue. Soft tissue sarcomas like hers have limited treatment options with only 14% responding to chemotherapy.
Read More
Colorectal cancer is the third most commonly occurring cancer in men, and the second in women. Yet every year 130 million people around the world between the ages of 50-74 remain unscreened. Rhythm Biosciences (ASX: RHY) are not complacent with that number and are working on an innovative solution to aid diagnosis of this major
Read More
From dental devices to jet engines, 3D printing is quickly becoming mainstream. Its use is moving well beyond prototyping and toys, towards industrial applications. Leading the way in the commercialisation of industrial 3D printers is AML3D (ASX: AL3), and their market update today proves that they plan on staying ahead of the game. The Company
Read More
Injury is inevitable in both elite and recreational sport. Most cuts, bruises, strains and tears can be remedied in a relatively short time frame with minimal ongoing issues. Traumatic brain injuries are quite the opposite. They can be debilitating, life altering and career ending. Following increased researcher interest and the findings of multiple studies, the
Read More
In this episode of Small Caps Watch, Emerald Financial’s Bronte Moore is joined by the CEO and Managing Director of Class Ltd (ASX: CL1) Andrew Russell as he provides an overview of the company’s fintech offering, their recent success, and plans for the future. Click below to watch. Class invites investors to join their
Read More
Mental illness will have an impact on 45% of Australians at some point in their lifetime. While the world is becoming increasingly aware of mental health conditions, little is being done to redefine the diagnostics. Currently, the gold standard in the diagnosis of mental illness is The Diagnostic and Statistical Manual of Mental Disorders (DSM5).
Read More
A power balance is in the process of shifting in the retail world where brand loyalty is one of the most valuable assets a consumer owns, often unknown to the consumer themselves. Identifying this changing trend, eCommerce company Mobecom (ASX: MBM) has acquired rewards business Neat Ideas to enhance their customer engagement platform. Core to
Read More
As one of Australia’s most successful funds in the small cap space returning more than 100% in the past 12 months, savvy investors may be intrigued to see Microequities has progressively increased their holding in one fintech company over the past 12 months. Specialising in the small caps sector, the Microequities Pure Microcap Value Fund
Read More
Australian’s are slowly pulling down their masks to embrace a new normal in the wake of the pandemic. Travel, at least domestically, is returning to pre-covid levels, a welcome change for those working in and around one of the hardest hit industries. Amongst those relieved companies is Ingenia Communities (ASX: INA). The Company is welcoming
Read More
Having built one of the most comprehensive networks of banking service partners over the past two years, digital payments company Novatti Group (ASX: NOV) has been noticed on the global stage, securing $18 million in funding for the launch of their planned neobank. The funding commitment comes from BC Investment Group (BC Invest) which offers
Read More
